|
Real-time
Oslo Bors
18:45:00 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.7000 NOK | +40.56% |
|
-.--% | -49.28% |
| 09-03 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Market Cap | 44.28M 4.81M 4.31M 3.97M 3.59M 6.72M 457M 6.84M 47.3M 18.99M 240M 18.07M 17.68M 758M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.37M 2.21M 1.98M 1.82M 1.65M 3.09M 210M 3.15M 21.76M 8.73M 111M 8.31M 8.14M 349M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
28.08% | Yield 2024 * |
-
| Yield 2025 | - |
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| EXTX | Real-time | |
Deutsche Boerse AG
| 56F | Delayed |
| 1 day | +40.56% | ||
| 1 month | +7.69% | ||
| 6 months | -51.39% | ||
| Current year | -49.28% |
| 1 month | 0.43 |  | 0.9 |
| Current year | 0.43 | | 2.7 |
| 1 year | 0.43 | | 2.7 |
| 3 years | 0.43 | | 12.5 |
| 5 years | 0.43 | | 21 |
| 10 years | 0.43 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 06/06/2022 |
Svein Kvåle
COO | Chief Operating Officer | - | 01/01/2012 |
John Edminson
DFI | Director of Finance/CFO | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 22/06/2018 | |
Anders Wold
CHM | Chairman | - | 08/06/2022 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/01/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 04/01/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +40.56% | -.--% | -55.41% | -94.35% | 4.7M | |
| -0.62% | -1.87% | +42.87% | +67.17% | 63.77B | |
| -1.24% | +2.18% | +12.31% | +72.03% | 56.37B | |
| +0.88% | +2.14% | +20.25% | +102.62% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +48.51% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +104.26% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +840.10% | 41B | |
| -3.35% | +27.67% | +102.95% | +91.69% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +47.05% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +350.50% | 24.7B | |
| Average | +3.56% | +7.16% | +36.48% | +162.96% | 39.43B | |
| Weighted average by Cap. | -0.60% | +5.44% | +47.37% | +173.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.61 0.01 0.06 0.03 0.32 0.02 0.02 1.01 |
| Net income | -52.33M -5.69M -5.1M -4.69M -4.25M -7.94M -540M -8.09M -55.89M -22.44M -284M -21.35M -20.9M -896M | -86.97M -9.45M -8.47M -7.79M -7.06M -13.19M -898M -13.44M -92.88M -37.29M -472M -35.48M -34.73M -1.49B |
| Net Debt | -98.89M -10.75M -9.63M -8.86M -8.02M -15M -1.02B -15.28M -106M -42.4M -537M -40.35M -39.49M -1.69B | -23.91M -2.6M -2.33M -2.14M -1.94M -3.63M -247M -3.7M -25.54M -10.25M -130M -9.76M -9.55M -409M |
Employees
11
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
